RNA Study: Potential Drug Target or Biomarker (G106480653)

Target Name: RNU6-1263P

NCBI ID: G106480653

RNU6-1263P

Other Name(s): RNA, U6 small nuclear 1263, pseudogene

RNA Study: Potential Drug Target or Biomarker

RNA, U6 small nuclear 1263, pseudogene (RNU6-1263P) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a small RNA molecule, with a length of approximately 200 nucleotides, and a typical width of 12-15 nucleotides.

RNU6-1263P is a key player in the regulation of gene expression in various organisms, including humans. It is a non-coding RNA molecule that functions as a regulator of gene expression, specifically it can act as a negative regulator to ensure that genes are only expressed at the appropriate levels.

One of the unique features of RNU6-1263P is its highly specificity for its target genes. It is known to regulate gene expression in various organisms, including bacteria, yeast, and plants. Additionally, it is highly expressed in various tissues and cells, including the brain, heart, and muscle.

RNU6-1263P has also been shown to play a role in the development and progression of various diseases, including cancer. It has been shown to be downregulated in various types of cancer, such as breast cancer, and have been shown to be upregulated in cancer-associated tissues, such as the bloodstream.

Because of its potential as a drug target, RNU6-1263P is being targeted for further research and development. Studies have shown that inhibiting the activity of RNU6-1263P has the potential to be a effective treatment for various diseases, including cancer.

In addition to its potential as a drug target, RNU6-1263P also has potential as a biomarker. Its highly specific regulation of gene expression makes it a valuable tool for the study of gene function and regulation. Additionally, its expression patterns can be used as a diagnostic tool for various diseases, including cancer.

In conclusion, RNU6-1263P is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its highly specific regulation of gene expression and its relationship to the development and progression of various diseases make it an attractive target for further research and development. As the field of RNA regulation continues to grow, it will be interesting to see how these studies will progress and what new discoveries will be made about RNU6-1263P and its potential as a drug target and biomarker.

Protein Name: RNA, U6 Small Nuclear 1263, Pseudogene

The "RNU6-1263P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU6-1263P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets